COVID-19 Antithrombotic Rivaroxaban Evaluation

NCT04757857 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
660
Enrollment
OTHER
Sponsor class

Stopped Sustained reduction in the number of new COVID-19 cases as well as lower than expected event rates

Conditions

Interventions

Sponsor

Hospital Alemão Oswaldo Cruz

Collaborators